Skip to main content
Clinical Trials/NL-OMON56245
NL-OMON56245
Recruiting
Not Applicable

Elucidating the high cardiovascular disease risk in South Asians: focus on monocyte phenotype and incretin hormones - CAMI study

Interne Geneeskunde0 sites48 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Interne Geneeskunde
Enrollment
48
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Sponsor
Interne Geneeskunde

Eligibility Criteria

Inclusion Criteria

  • \- Males and females of South Asian or Dutch European ethnicity
  • \- Age from 18 to 30 years old
  • \- BMI 18 \- 25 kg/m2
  • \- Capable of giving informed consent

Exclusion Criteria

  • \- (auto\-) immune disease(s) including type 1 or 2 diabetes mellitus, chronic
  • kidney disease, hepatic disease, inflammatory bowel disease, thyroid disease
  • and rheumatoid arthritis. \- Genetic lipid\-associated disorders such as familial
  • hypercholesterolemia \- Any chronic renal or hepatic disease \- Use of medication
  • known to influence glucose and/or lipid metabolism (e.g. beta\-blockers,
  • antidepressants, corticosteroids) \- Abuse of alcohol or other substances \-
  • Smoking \- Vigorous exercise (\>3 times/week) \- Milk or soy allergy \-
  • Contrainindications for the InBody720 scan, such as a pacemaker \- Participation
  • in an intensive weight loss program or vigorous exercise program during the
  • last year before the start of the study \- laboratory abnormalities that could

Outcomes

Primary Outcomes

Not specified

Similar Trials